Members

As of October.1, 2023
Board Members
Motoo Ueno President / Senior Advisor, Chugai Pharmaceutical Co., Ltd.
Tetsuo Nagano Managing Director / Professor Emeritus, The University of Tokyo
Hisanori Takanashi Executive Director / Corporate Adviser, Chugai Pharmaceutical Co.,Ltd.
Hirotoshi Akita Director / Specially Appointed Professor, Professor Emeritus, Research Division of Cancer Immunotherapy, Hokkaido University Hospital, Hokkaido University
Hidenori Ichijo Director / Professor, Lab. of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo
Tamao Endo Director / Senior Fellow, Tokyo Metropolitan Institute for Geriatrics and Gerontology
Toshio Kitamura Director / Director, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe
Osamu Nagayama Director / Honorary Chairman, Chugai Pharmaceutical Co.,Ltd.
Masahiro Nishijima Director / National Institute of Health Sciences / Counterfeit and Illegal Drugs Information Center
Toshifumi Hibi Director / Honorary Professor, Keio University, School of Medicine
Kohei Miyazono Director / Executive Director, RIKEN, Distinguished University Professor, Graduate School of Medicine, The University of Tokyo
Toshiaki Itagaki Auditor / Director, Executive Vice President & CFO, Chugai Pharmaceutical Co.,Ltd.
Masayoshi Kanai Auditor / Certified Public Accountant, Kanai CPA Office
Councilors
Hiroji Iwata Vice director and Chief of Breast Oncology, Aichi Cancer Center Hospital
Masato Kasuga Director, The Institute of Medical Science, Asahi Life Foundation
Tatsuhiko Kodama Project Leader, Cancer and Metabolism Project, RCAST, The University of Tokyo
Takaki Shimada Professor, Director of Center, Center for Preventive Medicine
Mikiko Sodeoka Chief Scientist, RIKEN
Masakuni Degawa Emeritus & Visiting Professor, University of Shizuoka
Tetsuo Noda Representative Director, Executive Director, Institute Director, Japanese Foundation for Cancer Research
Kazuichi Hayakawa Professor Emeritus, Institute of Nature and Environmental Technology, Kanazawa University
Yasunobu Hirata Honorary Director, Tokyo Teishin Hospital
Taro Matsumoto Professor, Nihon University School of Medicine
Shuki Mizutani Professor Emeritus, Tokyo Medical and Dental University
Mariko Y Momoi Professor Emeritus, Jichi Medical University
Hisafumi Yamada Director, Executive Vice President, Chugai Pharmaceutical Co.,Ltd.
Mamoru Watanabe Distinguished Professor, Tokyo Medical and Dental University, Advanced Research Institute
Selection Committee Members
Satomi Adachi-Akahane Professor, Department of Physiology, Faculty of Medicine, Toho University
Makoto Arita Professor, Division of Physiological Chemistry and Metabolism, Keio University Faculty of Pharmacy
Akiko Ishii-Watabe Director, Division of Biological Chemistry and Biologicals, National Institute of Health Sciences
Yutaka Inagaki Professor, Tokai University School of Medicine
Johji Inazawa Director, Specifically Appointed Professor, Research Core Center, Tokyo Medical and Dental University (TMDU)
Hideshi Inoue Professor Emeritus, Specially Appointed Professor, Tokyo University of Pharmacy and Life Sciences
Shin Enosawa Research Associate, National Center for Child Health and Development
Akio Ojida Professor, Pharmaceutical Sciences, Kyushu University
Takio Kitazawa Emeritus Professor, Rakuno Gakuen University
Hitoshi Kiyoi Professor, Department of Hematology and Oncology, Nagoya University Grauate School of Medicine
Yoshiaki Kubota Professor, Department of Anatomy, Keio University School of Medicine
Shoichiro Kurata Professor, Graduate School of Pharmaceutical Sciences, Tohoku University
Fumie Kobayashi Eminent Professor, Azabu University
Kiyosei Takasu Professor, Graduate School of Pharmaceutical Sciences, Kyoto University
Hideyo Takahashi Professor, Faculty of Pharmaceutical Sciences, Tokyo University of Science
Hitoshi Takizawa Director and Professor, International Research Center for Medical Sciences, Kumamoto University
Masahiro Tsuboi Department of Director and Chief, Deoartment of Thoracic Suregry, National Cancer Center Hospital East
Hidehiko Nakagawa Professor, Graduate School of Pharmaceutical Sciences, Nagoya City University
Kazuo Nagasawa Professor, Tokyo University of Agriculture and Technology
Hiroshi Nishina Director & Professor, Medical Research Institute, Tokyo Medical and Dental University
Kiyohiko Hatake Professor, Department of Hematology, Akasaka Sanno Medical Center
Kenjiro Hanaoka Professor, Faculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University
Ryuji Hamamoto Division Chief, Division of Medical AI Research and Development, National Cancer Center Research Institute
Akiyoshi Fukamizu Professor, Director, Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (TARA), University of Tsukuba
Naoya Fujita Center Director, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
Shigeo Murata Professor, Graduate School of Pharmaceutical Sciences, the University of Tokyo
Masato Yasui Professor and Chair, Department of Pharmacology, Keio University School of Medicine
Yuji Yamanashi Professor, Division of Genetics, The Institute of Medical Science, The University of Tokyo
Kazuo Yamamoto Professor, Department of Molecular and Tumor Pathology, Graduate School of Medicine, Chiba University
Kouichi Yoshinari Professor, School of Pharmaceutical Sciences, University of Shizuoka
IAAO Advisory Board Members
Bruce A. Chabner Professor, Harvard Medical School, USA
Kiyohiko Hatake Professor, Department of Hematology, Akasaka Sanno Medical Center
Chikashi Ishioka Professor, Tohoku University of School of Medicine, Japan
Yuko Kitagawa Professor, Keio University of School of Medicine, Japan
Hiroyuki Mano Director, National Cancer Center Research Institute, Japan
Kohei Miyazono Executive Director, RIKEN, Distinguished University Professor, Graduate School of Medicine, The University of Tokyo
Hitoshi Nakagama President, National Cancer Center, Japan
Hiroyoshi Nishikawa Chief, Division of Cancer Immunology, Research Institute/ Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Japan
Naoko Ohtani Professor, Graduate School of Medicine, Osaka Metropolitan University, Japan
Neal Rosen Chair, Medical Oncology, Memorial Sloan Kettering Cancer Center, USA
Josep Tabernero Director, Vall d’Hebron Institute of Oncology (VHIO), Spain
Masakazu Toi Director, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Japan
C-FINDs Staff
Toshikazu Urabe Secretary General
Shigetaka Kato Senior Manager
Taro Miyazaki Senior Manager, Editor-in-Chief
Hirotaka Hasegawa Senior Manager
Mizue Haga Senior Manager
Mitsumasa Saito Accountant
Yukiyo Uede Accountant